Javascript must be enabled to continue!
Digoxin: Review of Current Laboratory Practice and Considerations
View through CrossRef
Digoxin is a drug used for its effects on the heart, particularly its effect on rate and strength of contraction. Levels are particularly useful in clinical practice owing to its narrow therapeutic index, with toxicity and therapeutic levels being relatively close. Clinically, digoxin toxicity can be acute or chronic, and can manifest with signs and symptoms related to the gastrointestinal system, nervous system, and cardiovascular system. Given digoxin toxicity can lead to fatal dysrhythmias, accurate and reproducible analysis by the laboratory is essential in the treatment of patients with suspected digoxin toxicity. However, the laboratory workup for digoxin toxicity is not as simple as performing a digoxin level. Other factors such as cross-reacting molecules, the effect of other biochemical findings, and the effect of the digoxin antidote (anti-digoxin antibody fragments) on immunoassay results need to be considered in clinical settings where the results aren’t consistent with clinical findings. The laboratory is ideally placed to help with issues relating from these factors to digoxin level interpretation.
Title: Digoxin: Review of Current Laboratory Practice and Considerations
Description:
Digoxin is a drug used for its effects on the heart, particularly its effect on rate and strength of contraction.
Levels are particularly useful in clinical practice owing to its narrow therapeutic index, with toxicity and therapeutic levels being relatively close.
Clinically, digoxin toxicity can be acute or chronic, and can manifest with signs and symptoms related to the gastrointestinal system, nervous system, and cardiovascular system.
Given digoxin toxicity can lead to fatal dysrhythmias, accurate and reproducible analysis by the laboratory is essential in the treatment of patients with suspected digoxin toxicity.
However, the laboratory workup for digoxin toxicity is not as simple as performing a digoxin level.
Other factors such as cross-reacting molecules, the effect of other biochemical findings, and the effect of the digoxin antidote (anti-digoxin antibody fragments) on immunoassay results need to be considered in clinical settings where the results aren’t consistent with clinical findings.
The laboratory is ideally placed to help with issues relating from these factors to digoxin level interpretation.
Related Results
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Background: Digoxin is extensively prescribed for cardiac diseases, so its chronic or acute toxicity commonly occur. Although digoxin specific antibodies (anti-digoxin Fab) are rec...
Radioimmunoassay of Digoxin—Interference by Digitoxin
Radioimmunoassay of Digoxin—Interference by Digitoxin
Abstract
Digitoxin interference with radioimmunoassay of digoxin may present a problem in determining digoxin concentrations in the serum of patients treated with di...
ASSA13-13-6 Clinical Study of Prenatal Trans-Placental Digoxin Therapy For Fetal Heart Failure
ASSA13-13-6 Clinical Study of Prenatal Trans-Placental Digoxin Therapy For Fetal Heart Failure
Objective
Study the clinical efficacy and safety of transplacental digoxin therapy for foetal heart failure. Investigate the evaluation and treatment guiding valu...
Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure
Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure
To assess the effect of oral digoxin on left ventricular systolic function in elderly patients, radionuclide angiography was performed on 20 patients 74 years old or older before a...
Digoxin Therapy in Heart Failure and Atrial Fibrillation: A Pharmacotherapeutic Review for Pharmacists
Digoxin Therapy in Heart Failure and Atrial Fibrillation: A Pharmacotherapeutic Review for Pharmacists
Background: Digoxin, a cardiac glycoside derived from Digitalis lanata, has been used for decades in managing heart failure and atrial fibrillation. Despite its historical prominen...
Digoxin-quinidine interaction in patients with chronic renal failure.
Digoxin-quinidine interaction in patients with chronic renal failure.
We evaluated the effect of quinidine on digoxin pharmacokinetic in six patients with severe renal failure. Quinidine reduced the total body clearance of digoxin from 1.87 to 1.06 l...
Digoxin and Hypermagnesuria
Digoxin and Hypermagnesuria
In a recent issue of Nephron, Abu-Amer et al.[<xref ref-type="bibr" rid="ref1">1</xref>] reported the presence of hypermagnesuria in patients following acute intravenou...

